12 and 1 in Australia 3 months ago that we know off. IMU would have had enough patients to apply for registrational clinical trial late last year if the 6 patients for Cohort A were included. Also, there would have been delay in figuring out the combination and dosage of IL-2 for Cohort B.
IMU Price at posting:
2.6¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)